Amplification of 8q21 in breast cancer is independent of MYC and associated with poor patient outcome.
Standard
Amplification of 8q21 in breast cancer is independent of MYC and associated with poor patient outcome. / Choschzick, Matthias; Lassen, Paula; Lebeau, Annette; Marx, Andreas; Terracciano, Luigi; Heilenkötter, Uwe; Jänicke, Fritz; Bokemeyer, Carsten; Izbicki, Jakob R.; Sauter, Guido; Simon, Ronald.
In: MODERN PATHOL, Vol. 23, No. 4, 4, 2010, p. 603-610.Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review
Harvard
APA
Vancouver
Bibtex
}
RIS
TY - JOUR
T1 - Amplification of 8q21 in breast cancer is independent of MYC and associated with poor patient outcome.
AU - Choschzick, Matthias
AU - Lassen, Paula
AU - Lebeau, Annette
AU - Marx, Andreas
AU - Terracciano, Luigi
AU - Heilenkötter, Uwe
AU - Jänicke, Fritz
AU - Bokemeyer, Carsten
AU - Izbicki, Jakob R.
AU - Sauter, Guido
AU - Simon, Ronald
PY - 2010
Y1 - 2010
N2 - Copy number gains involving the long arm of chromosome 8, including high-level amplifications at 8q21 and 8q24, have been frequently reported in breast cancer. Although the role of the MYC gene as the driver of the 8q24 amplicon is well established, the significance of the 8q21 amplicon is less clear. The breast cancer cell line SK-BR-3 contains three separate 8q21 amplicons, the distal two of which correspond to putative target genes TPD52 and WWP1. To understand the effect of proximal 8q21 amplification on breast cancer phenotype and patient prognosis, we analyzed 8q21 copy number changes using fluorescence in situ hybridization (FISH) in a tissue microarray containing more than 2000 breast cancers. Amplification at 8q21 was found in 3% of tumors, and was associated with medullary type (P
AB - Copy number gains involving the long arm of chromosome 8, including high-level amplifications at 8q21 and 8q24, have been frequently reported in breast cancer. Although the role of the MYC gene as the driver of the 8q24 amplicon is well established, the significance of the 8q21 amplicon is less clear. The breast cancer cell line SK-BR-3 contains three separate 8q21 amplicons, the distal two of which correspond to putative target genes TPD52 and WWP1. To understand the effect of proximal 8q21 amplification on breast cancer phenotype and patient prognosis, we analyzed 8q21 copy number changes using fluorescence in situ hybridization (FISH) in a tissue microarray containing more than 2000 breast cancers. Amplification at 8q21 was found in 3% of tumors, and was associated with medullary type (P
KW - Adult
KW - Humans
KW - Aged
KW - Female
KW - Middle Aged
KW - Aged, 80 and over
KW - Treatment Outcome
KW - Prognosis
KW - Gene Dosage
KW - Kaplan-Meier Estimate
KW - Gene Amplification
KW - In Situ Hybridization, Fluorescence
KW - Chromosomes, Human, Pair 8 genetics
KW - Tissue Array Analysis
KW - Drug Resistance, Neoplasm genetics
KW - Breast Neoplasms genetics
KW - Genes, myc
KW - Adult
KW - Humans
KW - Aged
KW - Female
KW - Middle Aged
KW - Aged, 80 and over
KW - Treatment Outcome
KW - Prognosis
KW - Gene Dosage
KW - Kaplan-Meier Estimate
KW - Gene Amplification
KW - In Situ Hybridization, Fluorescence
KW - Chromosomes, Human, Pair 8 genetics
KW - Tissue Array Analysis
KW - Drug Resistance, Neoplasm genetics
KW - Breast Neoplasms genetics
KW - Genes, myc
M3 - SCORING: Zeitschriftenaufsatz
VL - 23
SP - 603
EP - 610
JO - MODERN PATHOL
JF - MODERN PATHOL
SN - 0893-3952
IS - 4
M1 - 4
ER -